Ann: Ceasing to be a substantial holder, page-119

Hi all,

As the old saying goes: when 2 lawyers express their opinions, they need a third person to be an adjudicator.

These days, I find this statement applying to every field, e.g. Medical Science (Covid) and Engineering Sciemce (4DS-Retention).

The more I read, the more I am confused to be honest.

I am heading to the Standford Uni in a few days time. Hoping to meeting up with Mr. Ting in person. I am not sure if I am allowed to or not. I cannot see any reason why I should be refused entry, as a share holder capacity, unless the technical team is still on holidays. I might be wrong but I will give it ago anyway!

I would appreciate if someone could help me in formulating 3 good questions to ask Mr Ting and DM.

My questions are:

1. Retention: If the results for retention are good - would that encapsulate a bigger market scale?

2. Are there are any market strategies in place? If so, when?

3. Should the company be concerned about the share price dropping? I know it may sound stupid, but I want to hear their views.

I will report, accordingly, as I believe in transparency and equality. No inside-trading.

Hope everyone is well.

Sam Nguyen